Table 1.
Summary of subject characteristics
| Mean | (Range) | |
|---|---|---|
| Age (years) | 31.1 | (21.5–38.7) |
| Height (cm) | 163.5 | (149.0–175.3) |
| Weight (kg) | 71.5 | (46.1–86.6) |
| BMI (kg/m2) | 26.6 | (20.8–28.9) |
| FSH (µg/L) | 0.211 | (0.089–0.376) |
| E2 (pg/mL) | 24.21 | (7.0–55.0) |
| LH (IU/L) | 0.719 | (0.1–1.4) |
| Prog (µg/L) | 0.652 | (0.08–1.49) |
| InhB (pg/mL) | 22.0 | (4.0–89.0) |
Demographics and measured baseline hormone levels for the 24 subjects receiving FE 999049
BMI body mass index, FSH follicle-stimulating hormone, E2 estradiol, LH luteinising hormone, Prog progesterone, InhB inhibin B